Empagliflozin reduces brain pathology in Alzheimer's disease and type 2 diabetes.

ABSTRACT:

SUBMITTER: Hierro-Bujalance C 

PROVIDER: S-EPMC11467955 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature